DrugPatentWatch Database Preview
Epizyme Inc Company Profile
» See Plans and Pricing
What is the competitive landscape for EPIZYME INC, and when can generic versions of EPIZYME INC drugs launch?
EPIZYME INC has one approved drug.
There are twenty-one US patents protecting EPIZYME INC drugs.
There are two hundred and fifty-eight patent family members on EPIZYME INC drugs in thirty-eight countries.
Summary for Epizyme Inc
| International Patents: | 258 |
| US Patents: | 21 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Epizyme Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Epizyme Inc | TAZVERIK | tazemetostat hydrobromide | TABLET;ORAL | 211723-001 | Jan 23, 2020 | RX | Yes | Yes | 9,333,217 | Start Trial | Start Trial | ||||
| Epizyme Inc | TAZVERIK | tazemetostat hydrobromide | TABLET;ORAL | 211723-001 | Jan 23, 2020 | RX | Yes | Yes | 10,369,155 | Start Trial | Start Trial | ||||
| Epizyme Inc | TAZVERIK | tazemetostat hydrobromide | TABLET;ORAL | 211723-001 | Jan 23, 2020 | RX | Yes | Yes | 9,872,862 | Start Trial | Start Trial | ||||
| Epizyme Inc | TAZVERIK | tazemetostat hydrobromide | TABLET;ORAL | 211723-001 | Jan 23, 2020 | RX | Yes | Yes | Start Trial | Start Trial | |||||
| Epizyme Inc | TAZVERIK | tazemetostat hydrobromide | TABLET;ORAL | 211723-001 | Jan 23, 2020 | RX | Yes | Yes | Start Trial | Start Trial | |||||
| Epizyme Inc | TAZVERIK | tazemetostat hydrobromide | TABLET;ORAL | 211723-001 | Jan 23, 2020 | RX | Yes | Yes | 9,688,665 | Start Trial | Start Trial | ||||
| Epizyme Inc | TAZVERIK | tazemetostat hydrobromide | TABLET;ORAL | 211723-001 | Jan 23, 2020 | RX | Yes | Yes | 8,691,507 | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Epizyme Inc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Hungary | E046790 | Start Trial |
| Poland | 2836491 | Start Trial |
| Japan | 6255382 | Start Trial |
| Japan | 2020011971 | Start Trial |
| Serbia | 59392 | Start Trial |
| Australia | 2013331380 | Start Trial |
| Taiwan | I529162 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
